Acadia Pharmaceuticals Inc. · NASDAQ:ACAD
Poole Jonathan exercised options for 2,010 Acadia Pharmaceuticals Inc. shares (Form 4)
Traded May 29, 2026 · Filed Jun 1, 2026
On May 29, 2026, Poole Jonathan (Director) exercised options for 2,010 Acadia Pharmaceuticals Inc. shares, leaving 2,010 shares. Filed Jun 1, 2026 (Form 4).
- Options exercised
- 2,010 shares
- Holding after
- 2,010 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 29, 2026 | Common Stock | Option exercise | 2,010 | 2,010 | Direct |
Source
Related
- Acadia Pharmaceuticals Inc.
- Poole Jonathan
- Acadia Pharmaceuticals Inc. shareholders
- Form 4 · Schneyer Mark C. · Aug 7, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Thompson Elizabeth H.Z. · Jul 31, 2026
- Form 4 · Kihara James · Jun 29, 2026
- Form 4 · Baker Brothers Life Sciences LP · Jun 2, 2026